Salts and Derivatives of Active Pharmaceutical Ingredients (API)
The salts of Active Pharmaceutical Ingredients (APIs) are compounds formed by the reaction of an acid with a base, resulting in an ionic equilibrium. These salts often improve the solubility and stability of APIs, facilitating their absorption in the body. API derivatives are chemical variants of an active ingredient that may have enhanced or modified properties to optimise therapeutic efficacy. API salts are used in the formulation of oral, injectable, and topical medications. Additionally, API derivatives can improve the pharmacokinetics of drugs, such as enabling controlled release of active substances.
At CymitQuimica, we provide API salts and derivatives with the necessary purity and quality for research and pharmaceutical formulation development.
Found 79792 products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Dexmedetomidine Related Compound C (5-[1-(2,3-Dimethylphenyl)ethyl]-1-ethyl-1H-imidazole)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C15H20N2Color and Shape:White SolidMolecular weight:228.16265Triamterene Related Compound B (2,7-diamino-4-hydroxy-6-phenylpteridine)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFormula:C12H10N6OColor and Shape:Light Yellow Crystalline PowderMolecular weight:254.09161Amoxicillin Related Compound B (L-amoxicillin)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H19O5N3SColor and Shape:PowderMolecular weight:365.10454Ramipril Related Compound D (Ethyl (S)-2-[(3S,5aS,8aS,9aS)-3-methyl-1,4-dioxodecahydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-2-yl]-4-phenylbutanoate)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C23H30N2O4Color and Shape:White PowderMolecular weight:398.22056Bendamustine Related Compound H (4-[5-({2-[(4-{5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoyl)oxy]ethyl}(2-chloroethyl)amino)-1-methyl-1H-benzimidazol-2-yl]butanoic acid)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C32H41Cl3N6O4Color and Shape:Off-White Yellow Orange SolidMolecular weight:678.22549Methylphenidate Hydrochloride Erythro Isomer Solution
CAS:Controlled ProductCompounds containing an unfused pyridine ring in the structure, nesoiFormula:C14H19NO2·HClColor and Shape:Clear LiquidMolecular weight:269.11826Clindamycin 2,3-Dipalmitate (Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-α-D-galacto-octopyranoside 2,3-dipalmitate monohydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C50H93ClN2O7S·HClColor and Shape:White Off-White SolidMolecular weight:936.61588Articaine Related Compound B (4-methyl-3-{[2-(propylamino)propanoyl]amino}thiophene-2-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C12H18N2O3SColor and Shape:PowderMolecular weight:270.10381Latanoprost Related Compound E ((Z)-7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(R)-3-hydroxy-5-phenylpentyl]cyclopentyl}-5-heptenoic acid)
CAS:Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFormula:C23H34O5Color and Shape:Yellow LiquidMolecular weight:390.24062Vecuronium Bromide Related Compound F (Piperidinium,1-[(2β,3α,5α,16β,17β)-17-acetyloxy-3-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C32H55BrN2O3Color and Shape:White Off-White PowderMolecular weight:594.33961Clonazepam Related Compound A (3-Amino-4-(2-chlorophenyl)-6-nitrocarbostyril)
CAS:Lactams not elsewhere specified or includedFormula:C15H10ClN3O3Color and Shape:Yellow-Orange PowderMolecular weight:315.04107Dexketoprofen Tromethamine
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormula:C16H14O3·C4H11NO3Color and Shape:White PowderMolecular weight:375.16819Prostaglandin B1 ((13E,15S)-15-Hydroxy-9-oxoprosta-8(12),13-dien-1-oic acid)
CAS:Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFormula:C20H32O4Color and Shape:White Off-White SolidMolecular weight:336.47 g/molAripiprazole Related Compound C (1-(2,3-dichlorophenyl)piperazine hydrochloride)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C10H12Cl2N2·HClColor and Shape:White PowderMolecular weight:230.03775Azacitidine Related Compound C (1-β-D-Ribofuranosyl-3-guanylurea picrate)
CAS:Sugars, chemically pure, other than sucrose, lactose, maltose, glucose and fructose; sugar ethers and sugar esters, and their salts, nesoiFormula:C7H14N4O5·C6H3N3O7Color and Shape:Yellow PowderMolecular weight:234.09642Benzhydrol
CAS:Aromatic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormula:C13H12OColor and Shape:White Off-White PowderMolecular weight:184.08882Losartan Related Compound E (4'-[({2-Butyl-5-[(5-{4'-[(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl]biphenyl-2-yl}-2H-tetrazol-2-yl)methyl]-4-chloro-1H-imidazol-1- yl}methyl)biphenyl-2-yl]tetrazol, potassium salt)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C44H43Cl2KN12OColor and Shape:White Off-White Crystalline PowderMolecular weight:865.90Dipyridamole Related Compound C (2,2'-{[6-chloro-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl]azanediyl}diethanol)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormula:C20H30ClN7O2Color and Shape:Light Yellow SolidMolecular weight:435.21495Sodium Picosulfate Related Compound A (4-[(Pyridin-2-yl)(4-hydroxyphenyl)methyl]phenyl sodium sulfate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C18H14NNaO5SColor and Shape:White PowderMolecular weight:379.04904Mebendazole Related Compound D (Methyl 5-benzoyl-1-methylbenzimidazol-2-ylcarbamate)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C17H15N3O3Color and Shape:SolidMolecular weight:309.11134
